¼¼°èÀÇ ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : Á¦Ç°º°, ±â¼úº°, ±¸¼º¿ä¼Òº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Wearable Atrial Fibrillation Detection Devices Market, By Product, By Technology, By Component, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1684281
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 311 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,612,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,598,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,017,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 32¾ï 9,032¸¸ ´Þ·¯·Î 2025³âºÎÅÍ 2032³â±îÁö CAGR 11.98%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå ¿ªÇÐ

½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÉÇ÷°üÁúȯÀº ½ÉÀ帶ºñ, ³úÁ¹Áß, ½É¹æ¼¼µ¿°ú °°Àº ºÎÁ¤¸Æ µîÀÇ ÁúȯÀ» Æ÷ÇÔÇϸç, Àü ¼¼°èÀûÀ¸·Î »ç¸Á·üÀÇ ÁÖ¿ä ¿øÀÎ Áß Çϳª·Î ²ÅÈ÷°í ÀÖ½À´Ï´Ù. °íÇ÷¾Ð, ´ç´¢º´, ºñ¸¸, ÁÂ½Ä »ýȰ½À°ü µî À§ÇèÀÎÀÚÀÇ À¯º´·ü Áõ°¡´Â ƯÈ÷ °í·ÉÈ­ »çȸ¿¡¼­ ½ÉÇ÷°üÁúȯÀÇ Áõ°¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ÀÌ·¯ÇÑ ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÉÀå °Ç°­ »óŸ¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ°í ½É¹æ¼¼µ¿°ú °°Àº »óŸ¦ Á¶±â¿¡ °æ°íÇÒ ¼ö ÀÖ´Â ¿þ¾î·¯ºí ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°í¿¡ µû¸£¸é, ½ÉÇ÷°ü°è ÁúȯÀº Àü ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎÀ¸·Î 2019³â »ç¸ÁÀÚ ¼ö´Â ¾à 1,790¸¸ ¸íÀ¸·Î Àü ¼¼°è »ç¸ÁÀÚ ¼öÀÇ 32%¸¦ Â÷ÁöÇÕ´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ Á¡Àº ÀÌ·¯ÇÑ »ç¸Á¿øÀÎÀÇ 85%°¡ ½ÉÀ帶ºñ¿Í ³úÁ¹Áß°ú °ü·ÃÀÌ ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ¼ÒºñÀÚÀÇ Àǽİú °Ç°­ ÀǽÄÀÇ Áõ°¡´Â ½ÃÀå È®´ëÀÇ ±âȸ¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÇÁ¶óÀ̹ö½Ã ¹× µ¥ÀÌÅÍ º¸¾È¿¡ ´ëÇÑ ¿ì·Á´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®

¿ì¸®ÀÇ ¿¬±¸ ºÐ¼®°¡°¡ °øÀ¯ ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¾à 11.98%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¿ëµµº°·Î´Â ½º¸¶Æ®¿öÄ¡°¡ 2024³â ÁÖ¿ä ¿ëµµ·Î ²ÅÇû½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ÁÖ¿ä ¼öÀÍ¿øÀ̾ú½À´Ï´Ù.

¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ¼¼°è ½ÃÀåÀº Á¦Ç°, ±â¼ú, ±¸¼º¿ä¼Ò, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó µ¶¸³Çü°ú ÅëÇÕÇü µÎ °¡Áö·Î ³ª´¹´Ï´Ù. µ¶¸³Çü ÀåÄ¡´Â ½É¹æ¼¼µ¿ °¨Áö ¹× ½ÉÀå ¸ð´ÏÅ͸µ¿¡ ƯȭµÈ Á¦Ç°À¸·Î, ƯÁ¤ ¿ëµµ¿¡ ¸Â´Â Á¤È®ÇÑ µ¥ÀÌÅÍ ¼öÁýÀ» Á¦°øÇÕ´Ï´Ù. ¹Ý¸é, ÅëÇÕÇü ½Ã½ºÅÛÀº ½É¹æ¼¼µ¿ °¨Áö ¹× ´Ù¾çÇÑ Ãß°¡ ±â´ÉÀ» Æ÷ÇÔÇÏ´Â ´Ù¿ëµµ ¿þ¾î·¯ºí ±â±â·Î, ÇÇÆ®´Ï½º ¶Ç´Â °Ç°­ ÃßÀû±âÀÇ È®ÀåµÈ ±â´ÉÀ¸·Î ÀÚÁÖ »ç¿ëµË´Ï´Ù.

½ÃÀåÀº ±¤Àü ¿ëÀû ¸ÆÆÄ(PPG), ½ÉÀüµµ(ECG), ±â°èÇнÀ(ML)À» °áÇÕÇÑ ÀΰøÁö´É(AI)ÀÇ ¼¼ °¡Áö ÇÙ½É ±â¼ú·Î ³ª´µ´Âµ¥, PPG´Â ±¤±â¹Ý ¼¾¼­¸¦ ÀÌ¿ëÇØ Ç÷·ù¸¦ ¸ð´ÏÅ͸µÇÏ°í ½É¹æ¼¼µ¿(AFib)°ú °ü·ÃµÈ ºÎÁ¤¸ÆÀ» °¨ÁöÇÕ´Ï´Ù. ½ÉÀåÀÇ Àü±âÀû Ȱµ¿À» Æ÷ÂøÇÏ´Â ½ÉÀüµµ(ECG)´Â ½É¹æ¼¼µ¿ °¨ÁöÀÇ Ç¥ÁØÀ¸·Î ¿©°ÜÁö°í ÀÖÀ¸¸ç, AI¿Í MLÀÇ ÅëÇÕÀº ½É¹æ¼¼µ¿ÀÇ ½ÅÈ£°¡ µÉ ¼ö ÀÖ´Â ¹Ì¹¦ÇÑ ºÎÁ¤¸ÆÀ» °¨ÁöÇϱâ À§ÇØ ´ë±Ô¸ð µ¥ÀÌÅͼ¼Æ®¸¦ ó¸®ÇÔÀ¸·Î½á ¿þ¾î·¯ºí ÀåÄ¡¸¦ °­È­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ AI¿Í MLÀÇ Á¶ÇÕÀº PPG¿Í ECG ±â¼úÀÇ °ÝÂ÷¸¦ Á¡Â÷ÀûÀ¸·Î ¸Þ¿ì°í µ¥ÀÌÅÍ ÇØ¼®À» °³¼±ÇÏ¿© ÀÓ»ó ¹× ¼ÒºñÀÚ ½ÃÀå ¸ðµÎ¿¡¼­ ´õ ³Î¸® ¹Þ¾Æµé¿©Áö°í ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ½É¹æ¼¼µ¿(AFib) °¨Áö ±â±â ½ÃÀåÀº ¸î °¡Áö Áß¿äÇÑ ±¸¼º¿ä¼Ò·Î ³ª´µ¸ç, °¢ ±¸¼º¿ä¼Ò´Â ÀåÄ¡ÀÇ Àü¹ÝÀûÀÎ ¼º´É°ú È¿°ú¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÁÖ¿ä ±¸¼º¿ä¼Ò´Â ¼¾¼­, ÇÁ·Î¼¼¼­, ¹èÅ͸®, µð½ºÇ÷¹ÀÌ, ¿¬°á ¸ðµâ·Î ±¸¼ºµË´Ï´Ù. ¼¾¼­´Â ½É¹Ú¼ö ¹× ¸®µë°ú °°Àº Áß¿äÇÑ »ý¸®Àû µ¥ÀÌÅ͸¦ ¼öÁýÇϱ⠶§¹®¿¡ ½É¹æ¼¼µ¿ °¨Áö ¹× ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÇÁ·Î¼¼¼­´Â ¼¾¼­¿¡¼­ ¾òÀº Á¤º¸¸¦ ºÐ¼®ÇÏ¿© ºÒ±ÔÄ¢ÇÑ ½ÉÀå ¹Úµ¿ ¸®µëÀÌ °¨ÁöµÇ¸é °æ°í¸¦ »ý¼ºÇÏ¿© Àû½Ã¿¡ °³ÀÔ ¹× Áø´ÜÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ¹èÅ͸®´Â ÀÌ·¯ÇÑ ¿þ¾î·¯ºí ±â±âÀÇ Àü¿øÀ¸·Î ÀÛ¿ëÇÏ¿© ÀæÀº ÃæÀüÀÌ ÇÊ¿ä ¾øÀÌ Áö¼ÓÀûÀÎ ÀÛµ¿°ú Àå½Ã°£ ¸ð´ÏÅ͸µ ±â´ÉÀ» º¸ÀåÇÕ´Ï´Ù. µð½ºÇ÷¹ÀÌ´Â »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º ¿ªÇÒÀ» ÇÏ¸ç ½Ç½Ã°£ ½ÉÀå °Ç°­ µ¥ÀÌÅÍ, °æ°í ¹× ¾Ë¸²¿¡ ´ëÇÑ ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù. Ä¿³ØÆ¼ºñƼ ¸ðµâÀº ¿þ¾î·¯ºí ±â±â¿Í ½º¸¶Æ®Æù, Ŭ¶ó¿ìµå ¼­ºñ½º, ÀÇ·á ½Ã½ºÅÛ µî ¿ÜºÎ Ç÷§Æû°úÀÇ µ¥ÀÌÅÍ µ¿±âÈ­¸¦ ÅëÇØ ½Ç½Ã°£ µ¥ÀÌÅÍ °øÀ¯ ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀ» Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °¢ ±¸¼º¿ä¼Ò´Â ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±âÀÇ ±â´É¼º, ½Å·Ú¼º, À¯È¿¼ºÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀ̸ç, ¼ÒºñÀÚ¿Í ÀÇ·á Àü¹®°¡ ¸ðµÎ¿¡°Ô ¸Å¿ì Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù.

½ÃÀåÀº ¿ëµµº°·Î ½º¸¶Æ® ¿öÄ¡, ÆÐÄ¡, ȦÅÍ ¸ð´ÏÅÍ, ±âŸÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. ¿þ¾î·¯ºí ½É¹æ¼¼µ¿(AFib) °¨Áö ±â±â ½ÃÀåÀº ´Ù¿ëµµ¼º, ±¤¹üÀ§ÇÑ º¸±Þ, ´Ù±â´É¼ºÀ¸·Î ÀÎÇØ ½º¸¶Æ®¿öÄ¡ ºÎ¹®ÀÌ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ½É¹æ¼¼µ¿ °¨Áö ±â¼úÀÌ Å¾ÀçµÈ ½º¸¶Æ®¿öÄ¡´Â ½Åü Ȱµ¿, ¼ö¸é ÆÐÅÏ, ½ºÆ®·¹½º ¼öÁذú °°Àº ´Ù¸¥ °Ç°­ ÁöÇ¥¸¦ ÃßÀûÇÏ´Â µ¿½Ã¿¡ »ç¿ëÀÚ¿¡°Ô ½ÉÀå °Ç°­À» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â Á¢±Ù °¡´ÉÇÏ°í Æí¸®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÆÐÄ¡, ȦÅÍ ¸ð´ÏÅÍ ¹× ±âŸ Ư¼ö ÀåÄ¡¿Í °°Àº ´Ù¸¥ ¿ëµµ°¡ ½ÃÀåÀÇ ¸íÈ®ÇÑ ¿ä±¸¸¦ ÃæÁ·½ÃŰ´Â ¹Ý¸é, ½º¸¶Æ® ¿öÄ¡´Â ÁÖ¿ä Ä«Å×°í¸®·Î ´«¿¡ ¶ë´Ï´Ù. ÀÌ·¯ÇÑ ¿ëµµ´Â ÀÏ»óÀûÀÎ ¼ÒºñÀÚ¿ë¿¡¼­ º¸´Ù Àü¹®ÀûÀÎ ÀÇ·á ¹× ÀÓ»ó¿ë¿¡ À̸£±â±îÁö ´Ù¾çÇÑ »ç¿ëÀÚ ¿ä±¸¿Í ȯ°æ¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó º´¿ø ¹× Ŭ¸®´Ð, ÀçÅÃÀÇ·á ÇöÀå, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍÀÇ µÎ °¡Áö ÁÖ¿ä ºÎ¹®À¸·Î ºÐ·ùµË´Ï´Ù. ÀÌµé °¢ ºÎ¹®Àº ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±âÀÇ Ã¤Åðú Ȱ¿ë¿¡ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¸ðµç ºÎ¹®Àº Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ, Àû½Ã °æ°í, ȯÀÚ Ä¡·á °³¼± µîÀÇ ÀÌÁ¡À» ´©¸®°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¿ø°Ý °Ç°­ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀçÅà °£È£ ºÐ¾ß°¡ Å©°Ô ¼ºÀåÇϰí ÀÖ´Ù´Â Á¡À» ÁÖ¸ñÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. ÀÌ Ä«Å×°í¸®´Â ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ Áõ°¡¿Í Áý¿¡¼­ Ä¡·á¸¦ ¹Þ°íÀÚ Çϴ ȯÀÚµéÀÇ ¼±È£¿¡ ÈûÀÔ¾î ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ½É¹æ¼¼µ¿ º´·ÂÀÌ Àְųª ½É¹æ¼¼µ¿ À§ÇèÀÌ ³ôÀº »ç¶÷µéÀº ¿þ¾î·¯ºí ±â±â¸¦ ÅëÇØ ½ÉÀå ¹Úµ¿ ¸®µëÀ» ¸ð´ÏÅ͸µÇϰí, ÃßÀ̸¦ °üÂûÇϰí, ¾Ë¸²À» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ÀåÄ¡´Â ÀϹÝÀûÀ¸·Î »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º¸¦ Ư¡À¸·Î Çϸç, ÀÇ·á Àü¹®°¡¿¡°Ô ¿øÈ°ÇÑ ÃßÀû ¹× º¸°í¸¦ À§ÇØ ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǰú ÅëÇյǴ °æ¿ì°¡ ¸¹½À´Ï´Ù.

¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : Áö¿ªº° ºÐ¼®

ºÏ¹Ì´Â Á¶±â Áø´Ü°ú ¸ÂÃã ÀÇ·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå È®´ë¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì¿¡¼­´Â ½É¹æ¼¼µ¿À» Æ÷ÇÔÇÑ ´Ù¾çÇÑ Áúȯ¿¡ ´ëÇÑ Á¶±â Áø´ÜÀÇ Áß¿äÇÑ ¿ªÇÒ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀº ¸ÂÃãÇü Á¤º¸¸¦ Á¦°øÇÏ´Â ±â¼úÀ» Ȱ¿ëÇÏ¿© °Ç°­ °ü¸®¿¡ Á¡Á¡ ´õ Àû±ØÀûÀ¸·Î Âü¿©Çϰí ÀÖ½À´Ï´Ù. Ç» ¸®¼­Ä¡ ¼¾ÅÍ(Pew Research Center)ÀÇ 2021³â Á¶»ç¿¡ µû¸£¸é, ¹Ì±¹ ¼ºÀÎÀÇ 21%°¡ ½º¸¶Æ®¿öÄ¡³ª ÇÇÆ®´Ï½º Æ®·¡Ä¿¿Í °°Àº ¿þ¾î·¯ºí °Ç°­ ÃßÀû±â¸¦ Á¤±âÀûÀ¸·Î »ç¿ëÇϰí ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÇÑÆí, À¯·´°ú ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áö¿øÀûÀÎ ÀÇ·á ½Ã½ºÅÛ, ±â¼ú ¹ßÀü, °³ÀÎÈ­µÈ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ »ó´çÇÑ ¼ºÀå ÀáÀç·ÂÀ» °¡Áø Áß¿äÇÑ Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : °æÀï »óȲ

¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀåÀÇ °æÀï ȯ°æÀº ±âÁ¸ ±â¼ú ±â¾÷µé°ú ÀÇ·á±â±â Á¦Á¶¾÷üµéÀÌ ½ÃÀå Çõ½Å°ú ÀÔÁö È®´ë¸¦ À§ÇØ Ä¡¿­ÇÑ °æÀïÀ» ¹úÀ̰í ÀÖ´Â °ÍÀ¸·Î Ư¡Áö¾îÁý´Ï´Ù. °¢ ¾÷üµéÀº ½É¹æ¼¼µ¿ °¨Áö Á¤È®µµ¸¦ ³ôÀÌ°í »ç¿ëÀÚ °æÇèÀ» Çâ»ó½Ã۱â À§ÇØ ÀΰøÁö´É, ¸Ó½Å·¯´×°ú °°Àº ÷´Ü ±â¼úÀ» µµÀÔÇÏ´Â µ¥ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ ½É¹æ¼¼µ¿ ¹ß»ýÀ» ¿¹ÃøÇϱâ À§ÇØ ±¤¹üÀ§ÇÑ µ¥ÀÌÅͼ¼Æ® ºÐ¼®¿¡ ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» Àû¿ëÇÏ´Â °ÍÀº ¾÷°è¿¡¼­ °áÁ¤ÀûÀÎ Â÷º°È­ ¿ä¼Ò·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº Âü¿© ¾÷üµéÀÌ ÀÇ·á Á¦°øÀÚ¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇÏ¿© ÀÚ»ç ±â±âÀÇ ÀÓ»óÀû À¯È¿¼ºÀ» ³ôÀ̰í ÀÖÀ¸¸ç, º´¿ø, Áø·á¼Ò, ¿ø°ÝÀÇ·á Ç÷§ÆûÀ» Æ÷ÇÔÇÑ Çù·Â °ü°è°¡ Á¡Á¡ ´õ ³Î¸® ÆÛÁö°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±âÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå »óȲ

Á¦7Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : Á¦Ç°º°

Á¦8Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : ±â¼úº°

Á¦9Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : ±¸¼º¿ä¼Òº°

Á¦10Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : ¿ëµµº°

Á¦11Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦12Àå ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ½ÃÀå : Áö¿ªº°

Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® : ¿þ¾î·¯ºí ½É¹æ¼¼µ¿ °¨Áö ±â±â ¾÷°è

Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Wearable Atrial Fibrillation Detection Devices Market size was valued at US$ 3,290.32 Million in 2024, expanding at a CAGR of 11.98% from 2025 to 2032.

Wearable Atrial Fibrillation Detection Devices are compact, non-invasive instruments that monitor and recognize AFib. This common heart rhythm disorder may lead to serious complications, including stroke, heart failure, and various cardiovascular issues. These devices employ sophisticated technology to continuously assess the heart's electrical signals, detecting irregular heartbeats characteristic of AFib. By providing convenience and user-friendliness, these wearable devices enable early identification, continuous monitoring, and personalized patient care.

Wearable Atrial Fibrillation Detection Devices Market- Market Dynamics

The increasing prevalence of Cardiovascular Disease is anticipated to drive the growth of the market.

Cardiovascular diseases, encompassing conditions such as heart attacks, strokes, and arrhythmias like atrial fibrillation, rank among the foremost causes of mortality across the globe. The increasing prevalence of risk factors, including hypertension, diabetes, obesity, and sedentary lifestyles, has significantly contributed to the rise in cardiovascular diseases, particularly within aging demographics. As the global incidence of these diseases escalates, there is a corresponding surge in the demand for wearable technology capable of continuously monitoring heart health and offering early alerts for conditions such as atrial fibrillation. The World Health Organization reports that cardiovascular diseases are the primary cause of death worldwide, with approximately 17.9 million fatalities attributed to these conditions in 2019, accounting for 32% of all global deaths. Notably, 85% of these deaths were linked to heart attacks and strokes. Additionally, heightened consumer awareness and health consciousness may present opportunities for market expansion. However, concerns regarding privacy and data security could impede market growth.

Wearable Atrial Fibrillation Detection Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.98% over the forecast period (2025-2032)

Based on Application segmentation, Smart Watches was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Wearable Atrial Fibrillation Detection Devices Market- Segmentation Analysis:

The Global Wearable Atrial Fibrillation Detection Devices Market is segmented on the basis of Product, Technology, Component, Application, End User, and Region.

The market is divided into two distinct categories based on the type of product: Standalone Devices and Integrated Systems. Standalone Devices are tailored specifically for the detection of atrial fibrillation and cardiac monitoring, providing precise and targeted data collection for specific applications. On the other hand, Integrated Systems are versatile wearable devices that encompass atrial fibrillation detection along with a range of additional features, frequently serving as fitness or health trackers with expanded functionalities.

The market is divided into three core technologies: Photoplethysmography (PPG), Electrocardiogram (ECG), and Artificial Intelligence (AI) combined with Machine Learning (ML). PPG utilizes light-based sensors to monitor blood flow and detect irregular heart rhythms associated with atrial fibrillation (AFib). ECG, which captures the heart's electrical activity, is considered the gold standard for AFib detection. The integration of AI and ML enhances wearable devices by processing large datasets to detect subtle irregularities that may signal AFib. This combination of AI and ML is progressively bridging the gap between PPG and ECG technologies, improving data interpretation and gaining broader acceptance in both clinical and consumer markets.

The market for Wearable Atrial Fibrillation (AFib) Detection Devices is divided into several essential components, each playing a vital role in the device's overall performance and effectiveness. The key components consist of Sensors, Processors, Batteries, Displays, and Connectivity Modules. Sensors are critical for detecting and monitoring AFib, as they gather important physiological data, such as heart rate and rhythm. Processors analyze the information obtained from the sensors and generate alerts when irregular heart rhythms are detected, facilitating timely intervention and diagnosis. Batteries act as the power source for these wearable devices, ensuring continuous operation and extended monitoring capabilities without the need for frequent recharging. Displays serve as user interfaces, providing access to real-time heart health data, alerts, and notifications, thus allowing users to easily track their heart rhythm and overall health. Connectivity Modules enable the synchronization of data between the wearable device and external platforms, including smartphones, cloud services, or healthcare systems, which support real-time data sharing and remote monitoring. Each of these components is essential for ensuring the functionality, reliability, and effectiveness of wearable AFib detection devices, making them invaluable for both consumers and healthcare professionals.

The market is divided into three categories based on Application: Smart Watches, Patches, Holter Monitors, and Others. The Smart Watches segment dominates the Wearable Atrial Fibrillation (AFib) Detection Devices market due to their versatility, widespread adoption, and multi-functional capabilities. Smartwatches equipped with AFib detection technology offer users an accessible and convenient way to monitor their heart health in real time, alongside tracking other health metrics such as physical activity, sleep patterns, and stress levels. While other applications like patches, Holter monitors, and other specialized devices serve distinct market needs, smartwatches stand out as the leading category. Each of these applications caters to different user needs and environments, ranging from everyday consumer use to more specialized medical and clinical applications.

The market is categorized into two primary segments based on end-users: Hospitals & Clinics, Homecare Settings, and Ambulatory Surgery Centers. Each of these segments plays a vital role in the adoption and utilization of wearable AFib detection devices, with all sectors reaping the benefits of continuous monitoring, timely alerts, and improved patient care. Notably, the homecare segment is witnessing substantial growth, driven by the rising demand for remote health monitoring solutions. This category is expanding rapidly, fueled by the increase in telehealth services and patient preferences for receiving care at home. Individuals with a history of AFib or those at elevated risk can utilize wearable devices to monitor their heart rhythms, observe trends, and receive notifications. Devices within this segment typically feature user-friendly interfaces and are often integrated with mobile applications for seamless tracking and reporting to healthcare professionals.

Wearable Atrial Fibrillation Detection Devices Market- Geographical Insights

North America leads in market expansion, driven by an increasing recognition of the significance of early diagnosis and personalized healthcare. There is a notable focus in North America on the critical role of early diagnosis for various medical conditions, including atrial fibrillation. Consumers are becoming increasingly proactive in managing their health through the use of technology that offers customized insights. A survey conducted by the Pew Research Center in 2021 revealed that 21% of adults in the United States regularly utilized wearable health trackers, such as smartwatches or fitness trackers. Meanwhile, Europe and the Asia-Pacific region are emerging as vital areas with considerable growth potential, attributed to supportive healthcare systems, advancements in technology, and a rising demand for personalized healthcare solutions.

Wearable Atrial Fibrillation Detection Devices Market- Competitive Landscape:

The competitive landscape of the Wearable Atrial Fibrillation Detection Devices market is characterized by significant rivalry among both established technology firms and medical device manufacturers, all aiming to innovate and expand their market presence. Companies are making substantial investments in the incorporation of cutting-edge technologies such as artificial intelligence and machine learning to improve the precision of AFib detection and enhance user experience. The application of machine learning algorithms for the analysis of extensive data sets to forecast potential AFib incidents serves as a crucial differentiator within the industry. Numerous participants are establishing partnerships with healthcare providers to bolster the clinical efficacy of their devices, with collaborations involving hospitals, clinics, and telehealth platforms becoming increasingly prevalent.

Recent Developments:

The atrial fibrillation (AFib) history feature of the Apple Watch has reached a notable achievement by being the first digital health technology to receive qualification under the FDA's Medical Device Development Tools (MDDT) program. This recognition pertains to its classification as class II photoplethysmography (PPG) analysis software intended for over-the-counter use.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL WEARABLE ATRIAL FIBRILLATION DETECTION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL WEARABLE ATRIAL FIBRILLATION DETECTION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

GLOBAL WEARABLE ATRIAL FIBRILLATION DETECTION DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

GLOBAL WEARABLE ATRIAL FIBRILLATION DETECTION DEVICES MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

GLOBAL WEARABLE ATRIAL FIBRILLATION DETECTION DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL WEARABLE ATRIAL FIBRILLATION DETECTION DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL WEARABLE ATRIAL FIBRILLATION DETECTION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Wearable Atrial Fibrillation Detection Devices Market Overview

2. Executive Summary

3. Wearable Atrial Fibrillation Detection Devices Key Market Trends

4. Wearable Atrial Fibrillation Detection Devices Industry Study

5. Wearable Atrial Fibrillation Detection Devices Market: Impact of Escalating Geopolitical Tensions

6. Wearable Atrial Fibrillation Detection Devices Market Landscape

7. Wearable Atrial Fibrillation Detection Devices Market - By Product

8. Wearable Atrial Fibrillation Detection Devices Market - By Technology

9. Wearable Atrial Fibrillation Detection Devices Market - By Component

10. Wearable Atrial Fibrillation Detection Devices Market - By Application

11. Wearable Atrial Fibrillation Detection Devices Market - By End User

12. Wearable Atrial Fibrillation Detection Devices Market- By Geography

13. Key Vendor Analysis- Wearable Atrial Fibrillation Detection Devices Industry

14. 360 Degree Analyst View

15. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â